Insider Transactions in Q4 2023 at Acelrx Pharmaceuticals Inc (ACRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+8.94%
|
$0
$0.73 P/Share
|
|
Oct 10
2023
|
Richard Afable Director |
BUY
Grant, award, or other acquisition
|
Direct |
581
+19.06%
|
-
|
|
Oct 10
2023
|
Stephen J Hoffman |
BUY
Grant, award, or other acquisition
|
Direct |
581
+19.37%
|
-
|
|
Oct 10
2023
|
Mark A Wan |
BUY
Grant, award, or other acquisition
|
Direct |
581
+19.37%
|
-
|
|
Oct 10
2023
|
Marina Bozilenko |
BUY
Grant, award, or other acquisition
|
Direct |
581
+18.23%
|
-
|
|
Oct 10
2023
|
Adrian Adams |
BUY
Grant, award, or other acquisition
|
Direct |
581
+4.95%
|
-
|
|
Oct 10
2023
|
Howard B Rosen Director |
BUY
Grant, award, or other acquisition
|
Direct |
581
+9.89%
|
-
|
|
Oct 10
2023
|
Jill Marie Broadfoot |
BUY
Grant, award, or other acquisition
|
Direct |
581
+21.62%
|
-
|